Literature DB >> 22154950

Inverse correlation between plasma oxysterol and LDL-cholesterol levels in hepatitis C virus-infected patients.

Mario Arciello1, Salvatore Petta, Valerio Leoni, Gino Iannucci, Giancarlo Labbadia, Carlo Cammà, Antonio Craxì, Clara Balsano.   

Abstract

BACKGROUND: Hepatitis C virus infection is characterised by enhanced oxidative stress, which can be measured quantitatively by plasma oxysterol concentration. These molecules may affect lipid metabolism through the activation of Liver X Receptors. Hepatitis C virus exploits host lipid metabolism to facilitate its replication and diffusion. In our study we aimed to evaluate and highlight the potential pathogenetic role of oxysterols, 7-ketocholesterol and 7-β-hydroxycholesterol, in hepatitis C virus-related lipid dysmetabolism.
METHODS: The study was performed in 42 patients with chronic hepatitis C (93% genotype 1b) and 38 non-alcoholic fatty liver disease patients. Plasma oxysterols 7-ketocholesterol and 7-β-hydroxycholesterol were determined by isotope dilution gas chromatography/mass spectrometry.
RESULTS: Gas chromatography/mass spectrometry revealed higher 7-ketocholesterol (71.2 ± 77.3 vs 30.4 ± 14.5; p<0.005) and 7-β-hydroxycholesterol (23.7 ± 20.6 vs 11.5 ± 4.9; p<0.001) plasma levels in hepatitis C virus patients. Furthermore, multivariate regression analysis highlighted an inverse independent correlation between high oxysterol levels and low low-density lipoprotein cholesterol (p=0.01 for 7-β-hydroxycholesterol; p=0.02 for 7-ketocholesterol) in the hepatitis C virus group; in contrast, the non-alcoholic fatty liver disease group showed a direct correlation between oxysterol levels and low-density lipoprotein-cholesterol (p<0.001 for 7-β-hydroxycholesterol; p=0.002 for 7-ketocholesterol).
CONCLUSION: These different correlations reveal profound differences in lipid dysmetabolism between chronic hepatitis C and non-alcoholic fatty liver disease patients.
Copyright © 2011 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22154950     DOI: 10.1016/j.dld.2011.10.022

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  6 in total

1.  Association of HIV, hepatitis C virus and liver fibrosis severity with interleukin-6 and C-reactive protein levels.

Authors:  Shailja Shah; Yifei Ma; Rebecca Scherzer; Greg Huhn; Audrey L French; Michael Plankey; Marion G Peters; Carl Grunfeld; Phyllis C Tien
Journal:  AIDS       Date:  2015-07-17       Impact factor: 4.177

2.  Evaluation of exome sequencing variation in undiagnosed ataxias.

Authors:  Erin Sandford; Jun Z Li; Margit Burmeister
Journal:  Brain       Date:  2015-04-04       Impact factor: 13.501

Review 3.  Lipids and HCV.

Authors:  M F Bassendine; D A Sheridan; S H Bridge; D J Felmlee; R D G Neely
Journal:  Semin Immunopathol       Date:  2012-10-31       Impact factor: 9.623

4.  Normocaloric low cholesterol diet modulates Th17/Treg balance in patients with chronic hepatitis C virus infection.

Authors:  Roberta Maggio; Carmela Viscomi; Paola Andreozzi; Gabriella D'Ettorre; Giovanni Viscogliosi; Barbara Barbaro; Manuele Gori; Vincenzo Vullo; Clara Balsano
Journal:  PLoS One       Date:  2014-12-22       Impact factor: 3.240

5.  Oxysterol/chitotriosidase based selective screening for Niemann-Pick type C in infantile cholestasis syndrome patients.

Authors:  Anna V Degtyareva; Tatiana Y Proshlyakova; Marina S Gautier; Dmitry N Degtyarev; Elena A Kamenets; Galina V Baydakova; Denis V Rebrikov; Ekaterina Y Zakharova
Journal:  BMC Med Genet       Date:  2019-07-11       Impact factor: 2.103

Review 6.  Mitochondrial dysfunctions and altered metals homeostasis: new weapons to counteract HCV-related oxidative stress.

Authors:  Mario Arciello; Manuele Gori; Clara Balsano
Journal:  Oxid Med Cell Longev       Date:  2013-11-24       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.